ストックスクリーナーアプリを入手
86.58
3.58%
2.99
プレマーケット:
85.16
-1.42
-1.64%
Guardant Health Inc (GH) 最新ニュース
Guardant Health (GH) partners with Manulife to launch Shield multi-cancer detection test in Asia - MSN
Guardant Health Ignites 5.6% Surge: A Volatile Breakout or a Trap for the Unwary? - Bitget
Verana and Guardant’s RWE Stack Aims to Solve Precision Oncology’s Data Challenges—Driving Growth Through Recurring Revenue and Broader Data Collections - Bitget
Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data - PR Newswire
Guardant Health Manulife Shield Partnership Highlights Asia Growth And Valuation Gap - Yahoo Finance
GH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Multiple analysts lift Guardant Health, Inc. (GH) targets on screening and data growth - MSN
Insiders Shake Up Guardant, Ovintiv, Redwire, Builders FirstSource, Permian - TipRanks
Why Guardant Health’s (GH) 2026 screening story reinforced Piper Sandler’s bullish view - MSN
Guardant Health (GH) Partners With Manulife to Launch Shield Multi-Cancer Detection Test in Asia - Insider Monkey
Guardant Health to present 28 abstracts on multiomic cancer research at AACR26 - Traders Union
Guardant Health, Inc. $GH Shares Sold by Polar Asset Management Partners Inc. - MarketBeat
GH Stock Price, Quote & Chart | GUARDANT HEALTH INC (NASDAQ:GH) - ChartMill
Insider Sell: Musa Tariq Sells Shares of Guardant Health Inc (GH) - GuruFocus
Guardant Health (GH) director Tariq Musa sells $30,655 in stock By Investing.com - Investing.com Australia
Insider Selling: Guardant Health (NASDAQ:GH) Director Sells 348 Shares of Stock - MarketBeat
Guardant Health (GH) director Tariq Musa sells $30,655 in stock - Investing.com
Guardant Health (NASDAQ: GH) director sells 348 company shares - Stock Titan
3 Reasons to Steer Clear of GH and One Alternative Stock Worth Buying - Bitget
Guardant Health Stock Analysis: Price Rise vs. Financial Risks | 2026News and Statistics - IndexBox
3 Reasons to Avoid GH and 1 Stock to Buy Instead - Yahoo Finance
15 Most Promising Stocks Under $100 to Buy - Insider Monkey
(GH) Risk Channels and Responsive Allocation - Stock Traders Daily
Cathie Wood’s ARK sells Guardant Health stock, buys Arcturus Therapeutics - Investing.com
Director at Guardant Health (GH) receives 232 shares via RSUs - Stock Titan
Guardant Health (NASDAQ: GH) Form 144 shows proposed insider sale of shares - Stock Titan
Guardant Health launches multi-cancer blood test in Asia through Manulife partnership - Mugglehead Investment Magazine
Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026 - BioSpace
Guardant Health acquires MetaSight amid positive 2026 financial outlook - MSN
Why Guardant Health’s (GH) 2026 Screening Story Reinforced Piper Sandler’s Bullish View - Insider Monkey
Guardant Health (GH) Co-CEO logs RSU grants, tax withholding and trust share transfer - Stock Titan
Guardant Health (GH) Co-CEO receives RSUs and shifts shares to trust - Stock Titan
Guardant Health (NASDAQ:GH) CFO Sells $261,120.00 in Stock - MarketBeat
Guardant Health launches Shield Multi-Cancer Detection Test in APAC market - BioSpectrum Asia
Guardant Health (GH) director acquires 249 shares via RSU vesting - Stock Titan
Guardant Health (NASDAQ: GH) CLO gains stock through RSU vesting - Stock Titan
Guardant Health (GH) CIO exercises RSUs and PBRSUs; 6,839 shares withheld for taxes - Stock Titan
Guardant Health (GH) CCO gains shares through RSU vesting and tax withholding - Stock Titan
Guardant Health (GH) CMO exercises RSUs; shares withheld to cover taxes - Stock Titan
Guardant Health (GH) CTO exercises 10,714 PSUs; 5,759 shares withheld for taxes - Stock Titan
Guardant Health (GH) CFO sells shares and reports RSU vesting - Stock Titan
Survey Supports Blood Tests for Colorectal Cancer Screening - Cure Today
Here’s Why Artisan Small Cap Fund Bets on Guardant Health (GH) - Insider Monkey
Oncology Molecular Diagnostics Market Growth 2026 | NGS, PCR - openPR.com
Singapore's Guardant Health launches Shield Multi-Cancer Detection (MCD) Test in APAC market - BioSpectrum Asia
Guardant Health Touts Quest Deal for Shield, Guardant360 Growth and FDA Milestones at Leerink Conference - MarketBeat
Algert Global LLC Raises Stock Holdings in Guardant Health, Inc. $GH - MarketBeat
Guardant Health Touts Hypergrowth in Guardant360, Reveal MRD and Shield CRC at Barclays Conference - MarketBeat
[144] Guardant Health, Inc. SEC Filing - Stock Titan
Guardant Health, Harris Poll Survey Shows 92% of Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered - National Today
Guardant Health, Inc. $GH Shares Bought by Iron Triangle Partners LP - MarketBeat
Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership - Business Wire
HighVista Strategies LLC Acquires 36,318 Shares of Guardant Health, Inc. $GH - MarketBeat
Fred Alger Management LLC Has $39.89 Million Holdings in Guardant Health, Inc. $GH - MarketBeat
Guardant Health, Inc. $GH Shares Purchased by First Light Asset Management LLC - MarketBeat
Guardant Health Shares Bought by Aquatic Capital Management - National Today
Guardant Health, Inc. $GH Shares Bought by Aquatic Capital Management LLC - MarketBeat
0.19%
0.04%
大文字化:
|
ボリューム (24 時間):